Showing results (41-50 of 525) with videos related to

Sort By:
Pageof 53
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Unique mechanism of action for escitalopram: does it hold the promise?Siegfried Kasper
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Anxiety disorders: under-diagnosed and insufficiently treatedSiegfried Kasper
European Archives of Psychiatry and Clinical Neuroscience|October 20, 2010
Is there a personalized medicine for mood disorders?Lucie Bartova, Andreas Berger, Lukas Pezawas
European Psychiatry : the Journal of the Association of European Psychiatrists|May 27, 2025
Symptom networks in major depressive disorder and treatment response: special focus on TRDAlexander Kautzky, Lucie Bartova, Markus Dold, et al.
The Journal of Clinical Psychiatry|December 12, 2017
Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III SampleAlexander Kautzky, Markus Dold, Lucie Bartova, et al.
The International Journal of Neuropsychopharmacology|September 5, 2020
Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant DepressionGernot Fugger, Markus Dold, Lucie Bartova, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 20, 2021
Melancholic features in major depression - a European multicenter studyMarkus Dold, Lucie Bartova, Gernot Fugger, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 26, 2021
Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorderGernot Fugger, Lucie Bartova, Markus Dold, et al.
Translational Psychiatry|February 6, 2019
Prefrontal networks dynamically related to recovery from major depressive disorder: a longitudinal pharmacological fMRI studyBernhard M Meyer, Ulrich Rabl, Julia Huemer, et al.
The International Journal of Neuropsychopharmacology|October 12, 2021
The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive DisorderLucie Bartova, Gernot Fugger, Markus Dold, et al.
Pageof 53